Login / Signup
Zsuzsanna Balla
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 7
Top Topics
Clinical Trial
Case Control
Open Label
Mesenchymal Stem Cells
Top Venues
Expert opinion on investigational drugs
Clinical reviews in allergy & immunology
Expert opinion on drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Henriette Farkas
,
Zsuzsanna Balla
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Expert opinion on investigational drugs
(2024)
Henriette Farkas
,
Zsuzsanna Balla
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Expert opinion on investigational drugs
33 (3) (2024)
Henriette Farkas
,
Zsuzsanna Balla
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Expert opinion on investigational drugs
(2024)
Henriette Farkas
,
Zsuzsanna Balla
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Expert opinion on investigational drugs
33 (3) (2024)
Henriette Farkas
,
Zsuzsanna Balla
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Expert opinion on investigational drugs
33 (3) (2024)
Henriette Farkas
,
Zsuzsanna Balla
A safety review of prophylaxis drugs for adolescent patients with hereditary angioedema.
Expert opinion on drug safety
(2023)
Zsuzsanna Balla
,
Bettina Ignácz
,
Lilian Agnes Varga
,
Kinga Viktória Kőhalmi
,
Henriette Farkas
How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?
Clinical reviews in allergy & immunology
61 (1) (2021)